Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2024

Open Access 01-12-2024 | Arterial Diseases | Research

Contrasting the relationship of serum uric acid/albumin ratio on quantitative flow ratio with other multiple composite parameters in patients with suspected coronary artery disease

Authors: Jin Liu, Han Wei, Xuanzhi Zhu, Huangjun Liu, Lijun Jin

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Objective

The aim of this study was to investigate the association between quantitative coronary flow reserve (CFR) and the blood uric acid/albumin ratio, as well as multiple clinical parameters, in order to assess the severity of coronary artery functional stenosis.

Methods

This retrospective cross-sectional study included 257 suspected coronary artery disease patients who underwent coronary angiography (CAG) and quantitative flow ratio (QFR) examinations in the Department of Cardiovascular Medicine at the First Affiliated Hospital of Yangtze University in Jingzhou City, China, between September 2022 and March 2023. The study subjects were divided into two groups based on their QFR values: QFR ≤ 0.80 group and QFR > 0.80 group. Correlation of uric acid-to-albumin ratio (UAR), high-density lipoprotein ratio (MHR), systemic immune-inflammation index (SII), Systemic Inflammation Response Index (SIRI), and Aggregate Index of Systemic Inflammation (AISI) with coronary artery QFR was analyzed using univariate and multivariate logistic regression models, considering them as both continuous and binary variables.

Results

The QFR ≤ 0.80 group consisted of 83 patients, while the QFR > 0.80 group included 174 patients. Significant differences were observed between the QFR ≤ 0.80 and QFR > 0.80 groups in the following parameters: UAR (9.19 ± 2.47 vs 7.61 ± 1.91; p < 0.001), MHR (0.46 ± 0.19 vs 0.37 ± 0.16, p < 0.001), SII (674.98 ± 332.30 vs 571.43 ± 255.82; p = 0.006), SIRI (1.53 ± 0.83 vs 1.29 ± 1.10; p = 0.047), and AISI (340.22 ± 242.10 vs 243.97 ± 151.97; p < 0.001). ROC curve analysis revealed an area under the curve of 0.701 (CI: 0.633–0.770; p < 0.001) for UAR. In the univariate analysis, when treated as binary variables, high levels of UAR, MHR, SII, SIRI, and AISI were found to be significantly associated with the risk of QFR ≤ 0.80 (all P < 0.05). However, in the multivariate regression analysis, only high levels of UAR and AISI remained significantly associated with QFR ≤ 0.80 (all P < 0.05). When treated as continuous variables, the univariate analysis indicated that UAR (OR: 1.412, CI: 1.231–1.620, p < 0.001), e^MHR (OR: 1.394, CI: 1.151–1.687, p < 0.001), lnSII (OR: 1.001, CI: 1.000–1.002, p = 0.008), and lnAISI (OR: 2.695, CI: 1.539–4.719, p = 0.001) were significantly associated with QFR ≤ 0.80. In the multivariate analysis, UAR (OR: 1.373, CI: 1.187–1.587, p < 0.001) and AISI (OR: 2.217, CI: 1.309–3.757, p < 0.001) remained significantly associated with QFR ≤ 0.80.

Conclusions

The results of this study indicate a significant association between UAR and AISI with QFR ≤ 0.80, suggesting its potential role in predicting the extent of functional coronary artery stenosis in patients with CAD. Additionally, AIRI, identified as an inflammatory marker in the complete blood count, was found to exert influence on the severity of coronary artery physiology.
Literature
1.
go back to reference Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American college of cardiology/American heart association joint committee on clinical practice guideline. Circulation. 2022;145:e18–114.PubMed Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American college of cardiology/American heart association joint committee on clinical practice guideline. Circulation. 2022;145:e18–114.PubMed
2.
go back to reference Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25.ADSCrossRefPubMed Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25.ADSCrossRefPubMed
3.
5.
go back to reference Stratz C, Nührenberg T, Fiebich BL, et al. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients.[J]. Thromb Haemost. 2014;111:902–11.PubMed Stratz C, Nührenberg T, Fiebich BL, et al. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients.[J]. Thromb Haemost. 2014;111:902–11.PubMed
6.
go back to reference Mukherjee M, Brouilette S, Stevens S, et al. Association of shorter telomeres with coronary artery disease in Indian subjects [J]. Heart. 2009;95:669–73.CrossRefPubMed Mukherjee M, Brouilette S, Stevens S, et al. Association of shorter telomeres with coronary artery disease in Indian subjects [J]. Heart. 2009;95:669–73.CrossRefPubMed
7.
go back to reference Samani NJ, Boultby R, Butler R, et al. Telomere shortening in atherosclerosis [J]. Lancet. 2001;358:472–3.CrossRefPubMed Samani NJ, Boultby R, Butler R, et al. Telomere shortening in atherosclerosis [J]. Lancet. 2001;358:472–3.CrossRefPubMed
8.
go back to reference X Wei, Z Zhang, J Wei, et al. Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction [J]. Front Cardiovasc Med. 2023;10:1248655.CrossRef X Wei, Z Zhang, J Wei, et al. Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction [J]. Front Cardiovasc Med. 2023;10:1248655.CrossRef
9.
go back to reference P Wang, X Guo, Y Zhou, et al. Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population [J]. Front Endocrinol (Lausanne). 2022;13:944991.CrossRef P Wang, X Guo, Y Zhou, et al. Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population [J]. Front Endocrinol (Lausanne). 2022;13:944991.CrossRef
10.
go back to reference CA Yang, BL Chiang. Inflammasomes and human autoimmunity: A comprehensive review [J]. J Autoimmun. 2015;61:1–8.ADSCrossRef CA Yang, BL Chiang. Inflammasomes and human autoimmunity: A comprehensive review [J]. J Autoimmun. 2015;61:1–8.ADSCrossRef
11.
go back to reference G Dong, A Huang, L Liu. Platelet-to-lymphocyte ratio and prognosis in STEMI: A meta-analysis [J]. Eur J Clin Invest. 2021;51:e13386.CrossRef G Dong, A Huang, L Liu. Platelet-to-lymphocyte ratio and prognosis in STEMI: A meta-analysis [J]. Eur J Clin Invest. 2021;51:e13386.CrossRef
12.
go back to reference K Han, D Shi, L Yang, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention [J]. Ann Med. 2022;54:1667–77.CrossRef K Han, D Shi, L Yang, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention [J]. Ann Med. 2022;54:1667–77.CrossRef
13.
go back to reference Dziedzic EA, Gąsior JS, Tuzimek A, et al. The Association between Serum Vitamin D Concentration and New Inflammatory Biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response (SIRI)-In Patients with Ischemic Heart Disease.[J]. Nutrients. 2022;14:undefined.CrossRef Dziedzic EA, Gąsior JS, Tuzimek A, et al. The Association between Serum Vitamin D Concentration and New Inflammatory Biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response (SIRI)-In Patients with Ischemic Heart Disease.[J]. Nutrients. 2022;14:undefined.CrossRef
14.
go back to reference Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Neutrophil Counts, Neutrophil-to-Lymphocyte Ratio, and Systemic Inflammatory Response Index (SIRI) Predict Mortality after Off-Pump Coronary Artery Bypass Surgery.[J]. Cells. 2022;11:undefined.CrossRef Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Neutrophil Counts, Neutrophil-to-Lymphocyte Ratio, and Systemic Inflammatory Response Index (SIRI) Predict Mortality after Off-Pump Coronary Artery Bypass Surgery.[J]. Cells. 2022;11:undefined.CrossRef
15.
go back to reference Nurkoç SG, Karayiğit O. The Association Between No-Reflow and Serum Uric Acid/Albumin Ratio in Patients With Acute Myocardial Infarction Without ST Elevation [J]. Angiology. 2022;undefined:33197221139685. Nurkoç SG, Karayiğit O. The Association Between No-Reflow and Serum Uric Acid/Albumin Ratio in Patients With Acute Myocardial Infarction Without ST Elevation [J]. Angiology. 2022;undefined:33197221139685.
16.
go back to reference G Pei, R Liu, Wang L, et al. Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases [J]. BMC Cardiovasc Disord. 2023;23:451.CrossRef G Pei, R Liu, Wang L, et al. Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases [J]. BMC Cardiovasc Disord. 2023;23:451.CrossRef
17.
go back to reference M Jiang, J Yang, H Zou, et al. Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States [J]. Lipids Health Dis. 2022;21:30.CrossRef M Jiang, J Yang, H Zou, et al. Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States [J]. Lipids Health Dis. 2022;21:30.CrossRef
18.
go back to reference Toprak K, Yılmaz R, Kaplangoray M, et al. Comparison of the effect of uric acid/albumin ratio on coronary colleteral circulation with other inflammation-based markers in stable coronary artery disease patients.[J]. Perfusion. 2023;undefined:2676591231202105.CrossRef Toprak K, Yılmaz R, Kaplangoray M, et al. Comparison of the effect of uric acid/albumin ratio on coronary colleteral circulation with other inflammation-based markers in stable coronary artery disease patients.[J]. Perfusion. 2023;undefined:2676591231202105.CrossRef
19.
go back to reference S Li, H Chen, Li Zhou, et al. The uric acid to albumin ratio: a novel predictor of long-term cardiac mortality in patients with unstable angina pectoris after percutaneous coronary intervention [J]. Scand J Clin Lab Invest. 2022;82:304–10.CrossRef S Li, H Chen, Li Zhou, et al. The uric acid to albumin ratio: a novel predictor of long-term cardiac mortality in patients with unstable angina pectoris after percutaneous coronary intervention [J]. Scand J Clin Lab Invest. 2022;82:304–10.CrossRef
20.
go back to reference Çınar T, Şaylık F, Hayıroğlu Mİ, et al. The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction.[J]. Angiology. 2023;74:381–6.CrossRefPubMed Çınar T, Şaylık F, Hayıroğlu Mİ, et al. The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction.[J]. Angiology. 2023;74:381–6.CrossRefPubMed
21.
go back to reference B Xu, S Tu, L Song, et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial [J]. Lancet. 2021;398:2149–59.CrossRef B Xu, S Tu, L Song, et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial [J]. Lancet. 2021;398:2149–59.CrossRef
22.
go back to reference L Song, B Xu, S Tu, et al. 2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions [J]. J Am Coll Cardiol. 2022;80:2089–101.CrossRef L Song, B Xu, S Tu, et al. 2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions [J]. J Am Coll Cardiol. 2022;80:2089–101.CrossRef
23.
go back to reference Drugescu A, Roca M, Zota IM, et al. Value of the Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Predicting CPET Performance in Patients with Stable CAD and Recent Elective PCI.[J]. Medicina (Kaunas). 2022;58:undefined. Drugescu A, Roca M, Zota IM, et al. Value of the Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Predicting CPET Performance in Patients with Stable CAD and Recent Elective PCI.[J]. Medicina (Kaunas). 2022;58:undefined.
24.
go back to reference Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the Associations of Novel Inflammatory Biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)-With the Severity of Coronary Artery Disease and Acute Coronary Syndrome Occurrence.[J]. Int J Mol Sci. 2022;23:undefined.CrossRef Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the Associations of Novel Inflammatory Biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)-With the Severity of Coronary Artery Disease and Acute Coronary Syndrome Occurrence.[J]. Int J Mol Sci. 2022;23:undefined.CrossRef
25.
go back to reference Aziz MH, Sideras K, Aziz NA, et al. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study.[J]. nn Surg. 2019;270:139–46. Aziz MH, Sideras K, Aziz NA, et al. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study.[J]. nn Surg. 2019;270:139–46.
26.
go back to reference Yang Y, Song C, Jia L, et al. Prognostic Value of Multiple Complete Blood Count-Derived Indices in Intermediate Coronary Lesions.[J]. Angiology. 2023;undefined:33197231198678.CrossRef Yang Y, Song C, Jia L, et al. Prognostic Value of Multiple Complete Blood Count-Derived Indices in Intermediate Coronary Lesions.[J]. Angiology. 2023;undefined:33197231198678.CrossRef
27.
go back to reference GL Du, F Liu, H Liu, et al. Monocyte-to-High Density Lipoprotein Cholesterol Ratio Positively Predicts Coronary Artery Disease and Multi-Vessel Lesions in Acute Coronary Syndrome [J]. Int J Gen Med. 2023;16:3857–68.CrossRef GL Du, F Liu, H Liu, et al. Monocyte-to-High Density Lipoprotein Cholesterol Ratio Positively Predicts Coronary Artery Disease and Multi-Vessel Lesions in Acute Coronary Syndrome [J]. Int J Gen Med. 2023;16:3857–68.CrossRef
28.
go back to reference Linton MF, Yancey PG, Tao H, et al. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy.[J]. Circ Res. 2023;132:1521–45.CrossRefPubMed Linton MF, Yancey PG, Tao H, et al. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy.[J]. Circ Res. 2023;132:1521–45.CrossRefPubMed
29.
go back to reference F Şaylık, T Çınar, M Selçuk, et al. The Relationship between Uric Acid/Albumin Ratio and Carotid Intima-Media Thickness in Patients with Hypertension [J]. Arq Bras Cardiol. 2023;120:e20220819. F Şaylık, T Çınar, M Selçuk, et al. The Relationship between Uric Acid/Albumin Ratio and Carotid Intima-Media Thickness in Patients with Hypertension [J]. Arq Bras Cardiol. 2023;120:e20220819.
30.
go back to reference Çakmak EÖ, Bayam E, Çelik M, et al. Uric Acid-to-Albumin Ratio: A Novel Marker for the Extent of Coronary Artery Disease in Patients with Non-ST-Elevated Myocardial Infarction.[J]. Pulse (Basel). 2021;8:99–107.CrossRefPubMed Çakmak EÖ, Bayam E, Çelik M, et al. Uric Acid-to-Albumin Ratio: A Novel Marker for the Extent of Coronary Artery Disease in Patients with Non-ST-Elevated Myocardial Infarction.[J]. Pulse (Basel). 2021;8:99–107.CrossRefPubMed
31.
go back to reference S Maulana, A Nuraeni, B AdityaNugraha. The Potential of Prognostic Biomarkers of Uric Acid Levels in Coronary Heart Disease Among Aged Population: A Scoping Systematic Review of the Latest Cohort Evidence [J]. J Multidiscip Healthc. 2022;15:161–73.CrossRef S Maulana, A Nuraeni, B AdityaNugraha. The Potential of Prognostic Biomarkers of Uric Acid Levels in Coronary Heart Disease Among Aged Population: A Scoping Systematic Review of the Latest Cohort Evidence [J]. J Multidiscip Healthc. 2022;15:161–73.CrossRef
32.
go back to reference Mandurino-Mirizzi A, Demarchi A, Ruffinazzi M, et al. Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.[J]. J Cardiovasc Med (Hagerstown). 2020;21:337–9.CrossRefPubMed Mandurino-Mirizzi A, Demarchi A, Ruffinazzi M, et al. Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.[J]. J Cardiovasc Med (Hagerstown). 2020;21:337–9.CrossRefPubMed
33.
go back to reference R Hamaya, M Hoshino, Y Kanno, et al. Prognostic implication of three-vessel contrast-flow quantitative flow ratio in patients with stable coronary artery disease [J]. EuroIntervention. 2019;15:180–8.CrossRef R Hamaya, M Hoshino, Y Kanno, et al. Prognostic implication of three-vessel contrast-flow quantitative flow ratio in patients with stable coronary artery disease [J]. EuroIntervention. 2019;15:180–8.CrossRef
34.
go back to reference Liang L, Hou X, Bainey K, et al. The association between hyperuricemia and coronary artery calcification development: A systematic review and meta-analysis.[J]. Clin Cardiol. 2019;42:1079–86.PubMedCentralCrossRefPubMed Liang L, Hou X, Bainey K, et al. The association between hyperuricemia and coronary artery calcification development: A systematic review and meta-analysis.[J]. Clin Cardiol. 2019;42:1079–86.PubMedCentralCrossRefPubMed
35.
go back to reference Lazzeri C, Valente S, Chiostri M, et al. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience.[J]. Int J Cardiol. 2010;138:206–9.CrossRefPubMed Lazzeri C, Valente S, Chiostri M, et al. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience.[J]. Int J Cardiol. 2010;138:206–9.CrossRefPubMed
36.
go back to reference Erdoğan M, Erdöl MA, Öztürk S, et al. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis.[J]. Biomark Med. 2020;14:1553–61.CrossRefPubMed Erdoğan M, Erdöl MA, Öztürk S, et al. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis.[J]. Biomark Med. 2020;14:1553–61.CrossRefPubMed
37.
go back to reference Patel MR, Nørgaard BL, Fairbairn TA, et al. -Year Impact on Medical Practice and Clinical Outcomes of FFR: The ADVANCE Registry.[J]. JACC Cardiovasc Imaging. 2020;13:97–105.CrossRefPubMed Patel MR, Nørgaard BL, Fairbairn TA, et al. -Year Impact on Medical Practice and Clinical Outcomes of FFR: The ADVANCE Registry.[J]. JACC Cardiovasc Imaging. 2020;13:97–105.CrossRefPubMed
38.
go back to reference Z Jin, B Xu, X Yang, et al. Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes [J]. J Am Coll Cardiol. 2022;80:1254–64.CrossRef Z Jin, B Xu, X Yang, et al. Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes [J]. J Am Coll Cardiol. 2022;80:1254–64.CrossRef
39.
go back to reference R Zhang, HY Wang, K Dou, et al. Outcomes of Functionally Complete vs Incomplete Revascularization: Insights From the FAVOR III China Trial [J]. JACC Cardiovasc Interv. 2022;15:2490–502.CrossRef R Zhang, HY Wang, K Dou, et al. Outcomes of Functionally Complete vs Incomplete Revascularization: Insights From the FAVOR III China Trial [J]. JACC Cardiovasc Interv. 2022;15:2490–502.CrossRef
40.
go back to reference Bon-Kwon Koo, Joo Myung Lee, Doyeon Hwang,Practical Application of Coronary Physiologic Assessment: Asia-Pacific Expert Consensus Document: Part 1. [J] JACC: Asia,2023,undefined. Bon-Kwon Koo, Joo Myung Lee, Doyeon Hwang,Practical Application of Coronary Physiologic Assessment: Asia-Pacific Expert Consensus Document: Part 1. [J] JACC: Asia,2023,undefined.
41.
go back to reference C Liu, Z Yu, H Chen, et al. Relationship Between Immunoinflammation and Coronary Physiology Evaluated by Quantitative Flow Ratio in Patients With Coronary Artery Disease [J]. Front Cardiovasc Med. 2021;8:714276.CrossRef C Liu, Z Yu, H Chen, et al. Relationship Between Immunoinflammation and Coronary Physiology Evaluated by Quantitative Flow Ratio in Patients With Coronary Artery Disease [J]. Front Cardiovasc Med. 2021;8:714276.CrossRef
42.
go back to reference Wienemann H, Ameskamp C, Mejía-Rentería H, et al. Diagnostic performance of quantitative flow ratio versus fractional flow reserve and resting full-cycle ratio in intermediate coronary lesions [J]. Int J Cardiol. 2022;362:59–67.CrossRefPubMed Wienemann H, Ameskamp C, Mejía-Rentería H, et al. Diagnostic performance of quantitative flow ratio versus fractional flow reserve and resting full-cycle ratio in intermediate coronary lesions [J]. Int J Cardiol. 2022;362:59–67.CrossRefPubMed
43.
go back to reference E Aksakal, U Aksu, O Birdal, et al. Role of Systemic Immune-Inflammatory Index in Predicting the Development of In-Hospital Malignant Ventricular Arrhythmia in Patients With ST-Elevated Myocardial Infarction [J]. Angiology. 2023;74:881–8.CrossRef E Aksakal, U Aksu, O Birdal, et al. Role of Systemic Immune-Inflammatory Index in Predicting the Development of In-Hospital Malignant Ventricular Arrhythmia in Patients With ST-Elevated Myocardial Infarction [J]. Angiology. 2023;74:881–8.CrossRef
Metadata
Title
Contrasting the relationship of serum uric acid/albumin ratio on quantitative flow ratio with other multiple composite parameters in patients with suspected coronary artery disease
Authors
Jin Liu
Han Wei
Xuanzhi Zhu
Huangjun Liu
Lijun Jin
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-024-03763-9

Other articles of this Issue 1/2024

BMC Cardiovascular Disorders 1/2024 Go to the issue